R&D Views & Analysis | pharmaphorum

Views & Analysis

Patients

5 patient travel strategies to impact enrolment diversity in...

According to the latest CISCRP report, “having to travel to the study clinic” is patients’ top-cited participation burden

R&D

Supply chain resilience in pharma: Delivering consistency am...

In an interconnected economy, industries operating on an international scale are increasingly vulnerable to supply chain disruption.

R&D

Reducing drug shortages: The power of AI in pharma supply ch...

Drug shortages have long been a challenge in the pharmaceutical industry, causing significant disruptions to patient care and public health.

R&D

LSX World Congress – Day Two

On Day Two of 2024's LSX World Congress, we’ll hear about the biotech/biopharma IPO market, the 2024 US Presidential election, and about the future of digital health.

R&D

injection needle in hand inside blue surgical glove

Mpox is on the rise again as outbreak gathers pace

The original mpox outbreak began in 2022, but case numbers have rumbled on, despite countermeasures.

R&D

LSX World Congress – Day One

Day One will kick off with a couple of sessions on the investing landscape, including one featuring speakers from Google and Eli Lilly.